Half Year 2025 Danone SA Earnings Call Transcript
Key Points
- Danone SA (DANOY) reported a strong like-for-like sales growth of 4.2% in H1 2025, driven by a balanced contribution from volume/mix and price increases.
- The company achieved a 49 basis point improvement in recurring operating margin, reaching 13.2%, reflecting disciplined execution and operational productivity.
- Specialized Nutrition posted a stellar 8.7% net sales growth, driven by Aptamil's market share gains and sustained demand in medical nutrition.
- Danone SA (DANOY) generated EUR1.2 billion in free cash flow for the first half, maintaining a solid financial position.
- The company completed strategic acquisitions, including Kate Farms and Akkermansia, enhancing its portfolio in medical nutrition and gut health.
- Danone SA (DANOY) faced challenges in the Waters segment, with adverse weather conditions impacting sales in emerging markets like Mexico and Indonesia.
- The North American plant-based segment showed early signs of recovery but still requires significant improvement to unlock its full potential.
- Currency headwinds negatively impacted sales by 4.9% due to the euro's appreciation against major currencies.
- The company acknowledged that its dairy segment is not yet leading the market everywhere, indicating room for improvement.
- Despite progress, Danone SA (DANOY) is not yet satisfied with its supply chain operations and aims to achieve world-class management.
Good day and thank you for standing by. Welcome to Danone first-half 2025 results conference call and webcast. (Operator Instructions) Please note that today's conference is being recorded.
I would now like to hand the conference over to your speaker Mathilde Rodié, Head of Investor Relations of Danone. Please go ahead.
Good morning, everyone. Mathilde Rodie speaking, Head of Investor Relations. Thank you for being with us this morning for Danone's 2025 H1 Results Call. I'm here with our CEO, Antoine de Saint-Affrique; and our CFO, Juergen Esser, who will go through some prepared remarks before taking your questions. And before we start, I draw your attention to the disclaimer on Slide 37 of the presentation related to forward-looking statements and the definition of financial indicators that we'll refer to during the presentation.
And with that, let me hand it over to Antoine.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

